Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression.

Huang L, Malu S, McKenzie JA, Andrews MC, Talukder AH, Tieu T, Karpinets T, Haymaker C, Forget MA, Williams LJ, Wang Z, Mbofung RM, Wang ZQ, Davis RE, Lo RS, Wargo JA, Davies MA, Bernatchez C, Heffernan T, Amaria RN, Korkut A, Peng W, Roszik J, Lizée G, Woodman SE, Hwu P.

Clin Cancer Res. 2018 Jul 15;24(14):3366-3376. doi: 10.1158/1078-0432.CCR-17-2483. Epub 2018 Mar 1.

2.

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes.

Mbofung RM, McKenzie JA, Malu S, Zhang M, Peng W, Liu C, Kuiatse I, Tieu T, Williams L, Devi S, Ashkin E, Xu C, Huang L, Zhang M, Talukder AH, Tripathi SC, Khong H, Satani N, Muller FL, Roszik J, Heffernan T, Allison JP, Lizee G, Hanash SM, Proia D, Amaria R, Davis RE, Hwu P.

Nat Commun. 2017 Sep 6;8(1):451. doi: 10.1038/s41467-017-00449-z.

3.

SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity.

Park J, Talukder AH, Lim SA, Kim K, Pan K, Melendez B, Bradley SD, Jackson KR, Khalili JS, Wang J, Creasy C, Pan BF, Woodman SE, Bernatchez C, Hawke D, Hwu P, Lee KM, Roszik J, Lizée G, Yee C.

Cancer Immunol Res. 2017 Aug;5(8):618-629. doi: 10.1158/2326-6066.CIR-17-0051. Epub 2017 Jun 19.

4.

Distribution of corticotropin-releasing factor neurons in the mouse brain: a study using corticotropin-releasing factor-modified yellow fluorescent protein knock-in mouse.

Kono J, Konno K, Talukder AH, Fuse T, Abe M, Uchida K, Horio S, Sakimura K, Watanabe M, Itoi K.

Brain Struct Funct. 2017 May;222(4):1705-1732. doi: 10.1007/s00429-016-1303-0. Epub 2016 Sep 16.

PMID:
27638512
5.

Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target.

Alatrash G, Garber HR, Zhang M, Sukhumalchandra P, Qiu Y, Jakher H, Perakis AA, Becker L, Yoo SY, Dwyer KC, Coombes K, Talukder AH, John LSS, Senyukov V, Lee DA, Sergeeva A, He H, Ma Q, Armistead PM, Roszik J, Mittendorf EA, Molldrem JJ, Hawke D, Lizee G, Kornblau SM.

Leukemia. 2017 Jan;31(1):234-237. doi: 10.1038/leu.2016.249. Epub 2016 Aug 30. No abstract available.

6.

Grancalcin (GCA) modulates Toll-like receptor 9 (TLR9) mediated signaling through its direct interaction with TLR9.

Kim TW, Hong S, Talukder AH, Pascual V, Liu YJ.

Eur J Immunol. 2016 Mar;46(3):712-24. doi: 10.1002/eji.201545567. Epub 2016 Jan 12.

7.

Visualization of corticotropin-releasing factor neurons by fluorescent proteins in the mouse brain and characterization of labeled neurons in the paraventricular nucleus of the hypothalamus.

Itoi K, Talukder AH, Fuse T, Kaneko T, Ozawa R, Sato T, Sugaya T, Uchida K, Yamazaki M, Abe M, Natsume R, Sakimura K.

Endocrinology. 2014 Oct;155(10):4054-60. doi: 10.1210/en.2014-1182. Epub 2014 Jul 24.

PMID:
25057791
8.

Molecular epidemiology of tuberculosis in rural Matlab, Bangladesh.

Banu S, Uddin MK, Islam MR, Zaman K, Ahmed T, Talukder AH, Rahman MT, Rahim Z, Akter N, Khatun R, Brosch R, Endtz HP.

Int J Tuberc Lung Dis. 2012;16(3):319-26. doi: 10.5588/ijtld.11.0426.

PMID:
22640444
9.

Phospholipid scramblase 1 regulates Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells.

Talukder AH, Bao M, Kim TW, Facchinetti V, Hanabuchi S, Bover L, Zal T, Liu YJ.

Cell Res. 2012 Jul;22(7):1129-39. doi: 10.1038/cr.2012.45. Epub 2012 Mar 27.

10.

Serine 28 phosphorylation of NRIF3 confers its co-activator function for estrogen receptor-alpha transactivation.

Talukder AH, Li DQ, Manavathi B, Kumar R.

Oncogene. 2008 Sep 4;27(39):5233-42. doi: 10.1038/onc.2008.151. Epub 2008 Jun 2.

11.

Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cells.

Akinmade D, Talukder AH, Zhang Y, Luo WM, Kumar R, Hamburger AW.

Br J Cancer. 2008 Mar 25;98(6):1132-40. doi: 10.1038/sj.bjc.6604261. Epub 2008 Feb 19.

12.

Identification of Pax5 as a target of MTA1 in B-cell lymphomas.

Balasenthil S, Gururaj AE, Talukder AH, Bagheri-Yarmand R, Arrington T, Haas BJ, Braisted JC, Kim I, Lee NH, Kumar R.

Cancer Res. 2007 Aug 1;67(15):7132-8. Erratum in: Cancer Res. 2015 Jun 15;75(12):2580-1.

13.

Metastasis-associated protein 1 transgenic mice: a new model of spontaneous B-cell lymphomas.

Bagheri-Yarmand R, Balasenthil S, Gururaj AE, Talukder AH, Wang YH, Lee JH, Kim YS, Zhang X, Jones DM, Medeiros LJ, Stephens LC, Liu YJ, Lee N, Kim I, Kumar R.

Cancer Res. 2007 Aug 1;67(15):7062-7. Erratum in: Cancer Res. 2015 Jun 15;75(12):2582-3.

14.

Repression of Six3 by a corepressor regulates rhodopsin expression.

Manavathi B, Peng S, Rayala SK, Talukder AH, Wang MH, Wang RA, Balasenthil S, Agarwal N, Frishman LJ, Kumar R.

Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13128-33. Epub 2007 Jul 31.

15.

Phosphorylation-dependent regulation of nuclear localization and functions of integrin-linked kinase.

Acconcia F, Barnes CJ, Singh RR, Talukder AH, Kumar R.

Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6782-7. Epub 2007 Apr 9.

16.

Signaling-dependent and coordinated regulation of transcription, splicing, and translation resides in a single coregulator, PCBP1.

Meng Q, Rayala SK, Gururaj AE, Talukder AH, O'Malley BW, Kumar R.

Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5866-71. Epub 2007 Mar 26.

17.

An inherent role of integrin-linked kinase-estrogen receptor alpha interaction in cell migration.

Acconcia F, Manavathi B, Mascarenhas J, Talukder AH, Mills G, Kumar R.

Cancer Res. 2006 Nov 15;66(22):11030-8.

18.

Metastatic tumor antigen 3 is a direct corepressor of the Wnt4 pathway.

Zhang H, Singh RR, Talukder AH, Kumar R.

Genes Dev. 2006 Nov 1;20(21):2943-8. Epub 2006 Oct 18.

19.

Essential role of KIBRA in co-activator function of dynein light chain 1 in mammalian cells.

Rayala SK, den Hollander P, Manavathi B, Talukder AH, Song C, Peng S, Barnekow A, Kremerskothen J, Kumar R.

J Biol Chem. 2006 Jul 14;281(28):19092-9. Epub 2006 May 9.

20.

MTA1, a transcriptional activator of breast cancer amplified sequence 3.

Gururaj AE, Singh RR, Rayala SK, Holm C, den Hollander P, Zhang H, Balasenthil S, Talukder AH, Landberg G, Kumar R.

Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6670-5. Epub 2006 Apr 14. Erratum in: Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4147-8.

21.

P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation.

Rayala SK, Talukder AH, Balasenthil S, Tharakan R, Barnes CJ, Wang RA, Aldaz CM, Khan S, Kumar R.

Cancer Res. 2006 Feb 1;66(3):1694-701.

22.

Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein.

Singh RR, Barnes CJ, Talukder AH, Fuqua SA, Kumar R.

Cancer Res. 2005 Nov 15;65(22):10594-601.

23.

CRIPak, a novel endogenous Pak1 inhibitor.

Talukder AH, Meng Q, Kumar R.

Oncogene. 2006 Mar 2;25(9):1311-9.

PMID:
16278681
24.

Growth factor regulation of a 26S proteasomal subunit in breast cancer.

Barnes CJ, Li F, Talukder AH, Kumar R.

Clin Cancer Res. 2005 Apr 15;11(8):2868-74.

25.

Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator.

Talukder AH, Gururaj A, Mishra SK, Vadlamudi RK, Kumar R.

Mol Cell Biol. 2004 Aug;24(15):6581-91.

26.

Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis.

Bagheri-Yarmand R, Talukder AH, Wang RA, Vadlamudi RK, Kumar R.

Development. 2004 Jul;131(14):3469-79. Retraction in: Development. 2015 Apr 1;142(7):1388.

27.

Upstream determinants of estrogen receptor-alpha regulation of metastatic tumor antigen 3 pathway.

Mishra SK, Talukder AH, Gururaj AE, Yang Z, Singh RR, Mahoney MG, Francí C, Vadlamudi RK, Kumar R.

J Biol Chem. 2004 Jul 30;279(31):32709-15. Epub 2004 May 28.

28.

Metastatic tumor antigen 1 short form (MTA1s) associates with casein kinase I-gamma2, an estrogen-responsive kinase.

Mishra SK, Yang Z, Mazumdar A, Talukder AH, Larose L, Kumar R.

Oncogene. 2004 May 27;23(25):4422-9.

PMID:
15077195
29.

MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions.

Talukder AH, Mishra SK, Mandal M, Balasenthil S, Mehta S, Sahin AA, Barnes CJ, Kumar R.

J Biol Chem. 2003 Mar 28;278(13):11676-85. Epub 2003 Jan 13.

30.
31.

A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm.

Kumar R, Wang RA, Mazumdar A, Talukder AH, Mandal M, Yang Z, Bagheri-Yarmand R, Sahin A, Hortobagyi G, Adam L, Barnes CJ, Vadlamudi RK.

Nature. 2002 Aug 8;418(6898):654-7.

PMID:
12167865
32.
33.

Regulation of elongation factor-1alpha expression by growth factors and anti-receptor blocking antibodies.

Talukder AH, Jorgensen HF, Mandal M, Mishra SK, Vadlamudi RK, Clark BF, Mendelsohn J, Kumar R.

J Biol Chem. 2001 Feb 23;276(8):5636-42. Epub 2000 Dec 4.

34.

Evidence of Rab3A expression, regulation of vesicle trafficking, and cellular secretion in response to heregulin in mammary epithelial cells.

Vadlamudi RK, Wang RA, Talukder AH, Adam L, Johnson R, Kumar R.

Mol Cell Biol. 2000 Dec;20(23):9092-101.

35.

Heregulin regulation of autocrine motility factor expression in human tumor cells.

Talukder AH, Adam L, Raz A, Kumar R.

Cancer Res. 2000 Jan 15;60(2):474-80.

36.
37.

Clusters of basic amino acids in midkine: roles in neurite-promoting activity and plasminogen activator-enhancing activity.

Akhter S, Ichihara-Tanaka K, Kojima S, Muramatsu H, Inui T, Kimura T, Kaneda N, Talukder AH, Kadomatsu K, Inagaki F, Muramatsu T.

J Biochem. 1998 Jun;123(6):1127-36.

38.

A novel truncated variant form of Ebk/MDK1 receptor tyrosine kinase is expressed in embryonic mouse brain.

Talukder AH, Muramatsu T, Kaneda N.

Cell Struct Funct. 1997 Aug;22(4):477-85.

39.

Limited proteolysis by chymotrypsin of midkine and inhibition by heparin binding.

Matsuda Y, Talukder AH, Ishihara M, Hara S, Yoshida K, Muramatsu T, Kaneda N.

Biochem Biophys Res Commun. 1996 Nov 1;228(1):176-81.

PMID:
8912655
40.
41.

Structural characteristics of heparin-line domain required for interaction of midkine with embryonic neurons.

Kaneda N, Talukder AH, Ishihara M, Hara S, Yoshida K, Muramatsu T.

Biochem Biophys Res Commun. 1996 Mar 7;220(1):108-12.

PMID:
8602827

Supplemental Content

Loading ...
Support Center